ALKBH5 and plasma cell myeloma: More importantly, we found that ALKBH5 deficiency in MM cells enhanced the RNA methylation of the HIPPO pathway-initiating protein SAV1, suppressed the activation of the HIPPO pathway, and ultimately reduced the proportion of myeloma stem cells.